1. Home
  2. AIMD vs QNME Comparison

AIMD vs QNME Comparison

Compare AIMD & QNME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ainos Inc.

AIMD

Ainos Inc.

SELL

Current Price

$1.24

Market Cap

10.6M

Sector

Health Care

ML Signal

SELL

QNME

Quanome Technologies Inc. Common Stock

HOLD

Current Price

$0.24

Market Cap

10.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIMD
QNME
Founded
1984
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Integrated Freight & Logistics
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
10.5M
IPO Year
2008
2024

Fundamental Metrics

Financial Performance
Metric
AIMD
QNME
Price
$1.24
$0.24
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 4.0M
573.1K
Earning Date
11-16-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 47.83
EPS
N/A
★ N/A
Revenue
$124,157.00
★ $5,850,681.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 498.95
111.79
52 Week Low
$0.43
$0.24
52 Week High
$3.88
$1.40

Technical Indicators

Market Signals
Indicator
AIMD
QNME
Relative Strength Index (RSI) 60.79 33.15
Support Level $0.50 N/A
Resistance Level $1.75 $0.43
Average True Range (ATR) 0.30 0.04
MACD 0.08 -0.01
Stochastic Oscillator 51.47 2.36

Price Performance

Historical Comparison
AIMD
QNME

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

About QNME Quanome Technologies Inc. Common Stock

Quanome Technologies Inc operates in the midstream segment of the pharmaceutical industrial ecosystem, operating between upstream pharmaceutical manufacturers and downstream medical end customers. It sources products from multiple manufacturers and suppliers, and distribute them to hospitals, pharmaceutical distributors and other healthcare providers. Its principal product categories include infusion products, foods for special medical purposes, and specialty pharmaceuticals. It operates in one reportable segment serves its customers by providing pharmaceutical products in China. The company generates a substantial percentage of its revenue from selling pharmaceutical products on a direct basis.

Share on Social Networks: